BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » parkinson's disease

Stem Cell Treatment for Parkinson’s Disease

May 2, 2020 By Cade Hildreth (CEO) 1 Comment

Feature | Stem Cell Treatment for Parkinson's Disease

At least 16 clinical trials and one physician-led study in Japan are exploring stem cells for Parkinson’s disease. Some of these trials are using stem cells as living therapies, while others are using stem cells to study causes of the disease and its progression.

This research progress is critical, because Parkinson’s disease debilitates the body and causes tremors and numbness, loss of motor function, and stooping. Eventually, left untreated, Parkinson’s disease leads to death. The good news is, researchers are showing significant results in their studies on the link between stem cells and Parkinson’s disease.

In this article:

  1. An Introduction to Stem Cells
  2. What Are Stem Cells?
  3. What Is Parkinson’s Disease?
  4. How Does Stem Cell Therapy Work?
  5. How Can Stem Cells Help Heal This Condition?
  6. Are We Close to a Widespread Solution?

[Read more…]

Filed Under: Stem Cells Tagged With: parkinson's disease

Parkinson’s Disease Treatment Using Reprogrammed Stem Cells

October 2, 2018 By Cade Hildreth (CEO) Leave a Comment

Feature | Parkinson's Disease Treatment Using Reprogrammed Stem Cells

Anyone who has ever watched a friend or loved one succumb to the slow degradation of Parkinson’s disease will understand the urge to cure it. Read on to learn more about how stem cells could be a possible treatment option for Parkinson’s disease.

In this article:

  • What Causes Parkinson’s Disease?
  • How Do Stem Cells Work?
  • What Stem Cells Did Scientists Use to Accomplish This?
  • What Are the Challenges of Using Stem Cells to Cure Parkinson’s?
  • What Are the Benefits?

[Read more…]

Filed Under: iPS Cells Tagged With: iPS cells, parkinson's disease

Parkinson’s Disease Clinical Trial to Launch in Japan | iPS Cell Trial

August 6, 2018 By Cade Hildreth (CEO) Leave a Comment

iPS cell clinical trial parkinson's disease

Japan will continue its dominance with iPS cell clinical trials with the launch of a physician-lead trial for Parkinson’s disease. In its July 2018 press announcement, Kyoto University announced that its University Hospital and the Center for iPS Cell Research and Application (CiRA) will launch the world’s first clinical trial for Parkinson’s disease to utilize an induced pluripotent stem cell (iPS cell) derived therapeutic product.

Existing iPS Cell Trials

This newest iPS cell trial represents only the third iPS cell trial to be undertaken worldwide. The other existing iPS cell trials are being conducted by the RIKEN Center for Developmental Biology (CDC) and Cynata Therapeutics (ASX:CYP), respectively. [Read more…]

Filed Under: iPS Cells Tagged With: clinical trial, cynata therapeutics, parkinson's disease, RIKEN

Kyoto University to Launch iPS Cell Clinical Trial for Parkinson’s Disease

August 5, 2018 By Cade Hildreth (CEO) Leave a Comment

iPS Cell Clinical Trial

July 30, 2018 (Kyoto, Japan) – Kyoto University Hospital, in partnership with the Center for iPS Cell Research and Application (CiRA), Kyoto University, has planned physician-initiated clinical trials for Parkinson’s disease that transplants dopaminergic progenitors1 generated from induced pluripotent stem (iPS) cells. The clinical trial notification was submitted to the Pharmaceutical and Medical Devices Agency (PMDA; the Japanese equivalent of the FDA) on June 4, 2018, and the clinical trials are scheduled to begin on August 1 this year. [Read more…]

Filed Under: iPS Cells, Press Releases Tagged With: clinical trial, iPS cells, parkinson's disease

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.